Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests

Go back to Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests
Textainer Group Holdings limited (NASDAQ: GH) Delayed: 166.66 +4.07 (2.50%)
Previous Close $162.59    52 Week High $5.84 
Open $162.29    52 Week Low $5.49 
Day High $171.22    P/E N/A 
Day Low $162.00    EPS $0.00 
Volume 2,535,627